Experts Warn of Disease Gaps While Ivermectin Gains Buzz
As public health experts raise alarms over critical gaps in disease preparedness, Ivermectin has emerged at the center of national healthcare debates. With concerns about the CDC’s capacity to manage outbreaks, questions around public trust, and the balance between prevention and treatment, the drug has regained visibility in policy discussions and research priorities. The...
0 Commenti 0 condivisioni 11 Views 0 Anteprima